白云山（600332）6月5日最新公布的投资者关系活动记录表显示，该公司于5月1日至5月31日接受东吴证券、兴业自营、嘉实基金等多家机构的特定对象调研。该公司就投资者关注的研发创新、国际化布局、核心业务发展、财务状况及投资者回报等问题进行了回应。 广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、...
Source Link白云山（600332）6月5日最新公布的投资者关系活动记录表显示，该公司于5月1日至5月31日接受东吴证券、兴业自营、嘉实基金等多家机构的特定对象调研。该公司就投资者关注的研发创新、国际化布局、核心业务发展、财务状况及投资者回报等问题进行了回应。 广州白云山医药集团股份有限公司的主营业务是中西成药、化学原料药、天然药物、生物医药、化学原料药中间体的研发、制造与销售；西药、中药和医疗器械的批发、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.